全文获取类型
收费全文 | 3502篇 |
免费 | 299篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 191篇 |
妇产科学 | 104篇 |
基础医学 | 583篇 |
口腔科学 | 110篇 |
临床医学 | 352篇 |
内科学 | 732篇 |
皮肤病学 | 165篇 |
神经病学 | 196篇 |
特种医学 | 278篇 |
外国民族医学 | 2篇 |
外科学 | 425篇 |
综合类 | 43篇 |
预防医学 | 233篇 |
眼科学 | 75篇 |
药学 | 145篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 172篇 |
出版年
2021年 | 28篇 |
2020年 | 26篇 |
2019年 | 48篇 |
2018年 | 56篇 |
2017年 | 39篇 |
2016年 | 44篇 |
2015年 | 61篇 |
2014年 | 90篇 |
2013年 | 142篇 |
2012年 | 132篇 |
2011年 | 165篇 |
2010年 | 139篇 |
2009年 | 117篇 |
2008年 | 138篇 |
2007年 | 156篇 |
2006年 | 135篇 |
2005年 | 142篇 |
2004年 | 133篇 |
2003年 | 164篇 |
2002年 | 129篇 |
2001年 | 98篇 |
2000年 | 83篇 |
1999年 | 95篇 |
1998年 | 97篇 |
1997年 | 101篇 |
1996年 | 82篇 |
1995年 | 70篇 |
1994年 | 44篇 |
1993年 | 65篇 |
1992年 | 67篇 |
1991年 | 74篇 |
1990年 | 49篇 |
1989年 | 85篇 |
1988年 | 79篇 |
1987年 | 68篇 |
1986年 | 56篇 |
1985年 | 47篇 |
1984年 | 35篇 |
1983年 | 31篇 |
1982年 | 39篇 |
1981年 | 38篇 |
1980年 | 40篇 |
1979年 | 23篇 |
1978年 | 24篇 |
1977年 | 19篇 |
1976年 | 27篇 |
1975年 | 21篇 |
1973年 | 13篇 |
1972年 | 14篇 |
1971年 | 15篇 |
排序方式: 共有3827条查询结果,搜索用时 31 毫秒
1.
Catecholaminergic polymorphic ventricular tachycardia is important to be diagnosed as an underlying disease in children with syncope and normal heart, because of its poor prognosis. CASE REPORT: A 3-year-old boy was referred for stress and emotion induced syncope. Primary ventricular arrhythmia, consisting of salvos of bidirectional ventricular tachycardia, was reproducibly induced by physical exertion. The syncopal events and severe arrhythmia disappeared with beta-blocking therapy. CONCLUSION: Despite its rare occurrence, catecholaminergic polymorphic ventricular tachycardia is an important cause of stress and emotion induced syncope and sudden death in children. 相似文献
2.
3.
4.
Pyomyositis: characteristics at CT and MR imaging 总被引:9,自引:0,他引:9
5.
AJ Larner MRCP 《International journal of clinical practice》1994,48(5):272-274
SUMMARY A case is reported of pseudohyperphosphataemia in association with a monoclonal gammopathy of undetermined significance. 相似文献
6.
In a limited group of open angle glaucoma patients treated twice daily with timoptol 0.5% and having by this treatment a mean intra-ocular pressure of 21-22 mmHg, the association of timoptol 0.5% with pilocarpine 2% respectively, lowered the intra-ocular pressure to an average of 17.8 mmHg and 16.6 mmHg after one and three weeks of continuous treatment. For this study, the patients have been divided into 3 groups: A group treated with timoptol 0.5% alone throughout the 49 days of the study. A group treated with timoptol 0.5%-pilocarpine 2% (timpilo 2) from day 21 to day 49. A final group treated with timoptol 0.5% until day 21 and then with timoptol 0.5%-pilocarpine 4% (timpilo 4) through out day 49. These patients stopped the treatment before the end of the study. Intra-ocular pressures were measured on days 0, 21 and 49. We found a higher drop of pressure (-4.8 mmHg) in the timpilo 2 group than in the timoptol 0.5% group (-1 mmHg) before instillation as well as 2 hours afterwards (-5.25 mmHg and -2 mmHg respectively). The secondary local effects were due to miotics agents. The secondary systemic effects were those inherent to beta-blockers. These results are comparable with a multicentric study of 220 patients, therefore statistically significant. 相似文献
7.
Differential anti-influenza activity among allelic variants at the Sus scrofa Mx1 locus. 总被引:1,自引:0,他引:1
M Palm M Leroy A Thomas A Linden D Desmecht 《Journal of interferon & cytokine research》2007,27(2):147-155
A promising way to oppose infectious challenges would be to improve the resistance of the target species through genetic selection. Theoretically, a candidate gene is available against influenza viruses since a resistance trait was fortuitously discovered in the A2G mouse strain. This trait was demonstrated to be correlated with the expression of a specific isoform of the type I interferon (IFN)-dependent protein MX, an isoform coded by a specific allele at the mouse Mx1 locus. Two allelic polymorphisms were described recently in the Sus scrofa homologous gene. In this study, the frequencies and distribution of both alleles were evaluated among European domestic pig and wild boar populations by PCR-RFLP, and the anti-influenza activity conferred by both MX1 isoforms was evaluated in vitro using transfection of Vero cells followed by flow cytometric determination of the fraction of influenza virus-infected cells among MX-producing and MX-nonproducing cell populations. A significant difference in the anti-influenza activity brought by the two MX1 isoforms was demonstrated, which suggests that a significant improvement of innate resistance of pigs by genetic selection might be feasible provided the differences found here in vitro are epidemiologically relevant in vivo. 相似文献
8.
9.
D De AJ Kanwar S Handa 《Journal of the European Academy of Dermatology and Venereology》2006,20(7):853-859
BACKGROUND: Diagnosis of atopic dermatitis (AD) depends on clinical features because no definitive diagnostic test exists. Criteria proposed by Hanifin and Rajka (Acta Derm Venereol (Stockh) 1980; Suppl 92: 44-47) were acceptable for hospital-based studies but were found not to be suitable for field studies. A UK working party formulated clinical diagnostic criteria that could be used in both hospital and epidemiological settings. Validation studies of the criteria showed widely variable results, probably due to different clinical settings and ethnicity. AIM AND OBJECTIVE: This study was undertaken to validate Hanifin and Rajka's criteria and to assess the comparative efficacy of their criteria and the UK working party's diagnostic criteria in the diagnosis of AD in a hospital setting in North India. SUBJECTS AND METHODS: This study serially included 101 patients with AD and 48 controls of paediatric age group. The study period was from July 2003 to December 2004. RESULTS: Hanifin and Rajka's criteria (sensitivity 96%, specificity 93.75%, positive predictive value 97% (PPV) and negative predictive value (NPV) 91.84%) had a statistical advantage over the UK working party's diagnostic criteria (sensitivity 86%, specificity 95.83%, PPV 97.75% and NPV 76.67%), with a P-value < 0.005. 相似文献
10.
SUMMARY Impotence is a common symptom which can cause considerable distress to both the sufferer and his partner. The use of pharmacotherapy to improve erectile function will continue to increase as safe and effective drugs are developed. However, restoring erectile function should not be the only treatment objective. It is also essential to address personal and emotional factors in the sufferer, conflicts in his relationship with his partner, and sexual problems in his partner, all of which may be instrumental in causing or maintaining the presenting impotence. We advocate a combined approach with appropriate medical treatment and sex and couple therapy 相似文献